Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function.
about
Lymphatic Vessels, Inflammation, and Immunity in Skin CancerPhosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endotheliumPreclinical lymphatic imaging.Lymphatic vessel density and function in experimental bladder cancer.VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease.The lymphatic system in health and disease.Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis.Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.Corneal lymphangiogenesis in herpetic stromal keratitisAn important role of lymphatic vessel activation in limiting acute inflammationVascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in miceMalignant melanoma in the elderly: different regional disease and poorer prognosis.Apelin attenuates UVB-induced edema and inflammation by promoting vessel functionThe cutaneous vascular system in chronic skin inflammationReduction of lymphatic vessels in photodamaged human skin.Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye diseaseUnderstanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Potential therapeutic strategies for lymphatic metastasis.Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity.Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A)Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration.Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease.Lymphangiogenesis, myeloid cells and inflammation.Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis.Ultraviolet light-induced changes of lymphatic and blood vasculature in skin and their molecular mechanisms.Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?The inflammatory response of lymphatic endothelium.Lymphatic vessels: new targets for the treatment of inflammatory diseases.Inflammatory lymphangiogenesis: cellular mediators and functional implications.Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation's fire?Low-molecular-weight hyaluronan (LMW-HA) accelerates lymph node metastasis of melanoma cells by inducing disruption of lymphatic intercellular adhesion.Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease.Adrenomedullin stabilizes the lymphatic endothelial barrier in vitro and in vivo.High lymph vessel density and expression of lymphatic growth factors in peritoneal endometriosis.Time-course study of different innate immune mediators produced by UV-irradiated skin: comparative effects of short and daily versus a single harmful UV exposure.
P2860
Q26778332-208F6CF1-C9AD-48BF-85EB-87B9E31580ABQ28741586-B6CBDD64-72A7-4587-A5A7-91D6D0E1B4B3Q30465292-4F333DF0-9F36-47FA-8E39-4FC81F92B6F7Q30481281-71D90D4E-FC34-4ACD-9177-BFAB8FC40359Q33615188-E39BE9EE-5EC2-44D4-A7F8-D20DDD2EE3AFQ33831778-95419D89-0C1F-4EC5-85E6-B9502A27A8EAQ34015299-FB43F4B3-BFC9-4A53-A7F6-C2ABCA890329Q34149752-910F7289-B91F-4F16-BEA7-403AE16FBE3BQ34161479-6A7CE4C0-83B1-40DA-8459-3BD750EDD646Q34674612-0040DD21-F107-4D92-9C2B-6E5404871FC1Q34997755-38824A30-88D2-4ACB-B279-B3C91046F132Q35146135-04E8C838-01C2-417C-8182-FFD2EA556A11Q35542768-746C5184-A016-4F05-AB8B-753E28BA603AQ35679447-36C651A4-4645-4462-A1A0-A8638725E93BQ36098582-163F6C29-531C-46A9-9E9F-F4FEAB655F95Q36098591-0C400751-678D-4A14-94C3-658AA98DED32Q36393036-CA7C2D9E-B703-4CE3-AEF5-FBFC0163D134Q36776787-EB8765BA-4DB5-490C-AEF5-A49BB1C55A4DQ36808641-E3BCAD9A-B3C9-48D9-B344-18549046A376Q36851512-57F48F8A-F525-4CB3-BE3A-32438C6ABC7EQ36867583-3B369061-7B46-47B5-BE26-9DC0C2C73F59Q36898186-71935868-B55A-4AC5-B630-A5464F3F6A0EQ37316589-458A0A0C-EF5B-491D-A885-779ADA5D51FDQ37413735-BDA58FDA-7B6A-4285-B1B5-DB9717EEEFD7Q37754580-62523B13-5C04-4971-B565-74E5ED285A26Q37943796-2DA1BEC6-81E4-4B59-A191-6F089AE3D106Q38012875-190B0607-D865-405A-AEE1-AA568B72AB9FQ38123280-72371427-39D8-475D-8307-031EC0E29BCBQ38155100-1EC883ED-CC33-42DE-B749-1960686A5448Q38161374-2D9D8DBC-731C-4420-95FB-D2AB099D553CQ38180633-3932219F-4B2B-4DFD-8894-1AFE90D488B2Q38739268-5BA26741-929A-4909-9DE4-7B8D02BA443EQ39079697-E8E7A269-F6A3-4CDD-83A7-3A616DB45558Q39543850-36A5AAD4-FDEE-4BC5-A852-AE2A5861DB6FQ42261790-E98E847F-AB45-4817-8B46-56C2F1D060C8Q43767186-A042C435-DFAD-4A7B-A23A-9532F5653122Q53038878-AD767976-AEA4-4699-9A37-C09635B5E423
P2860
Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Vascular endothelial growth fa ...... of lymphatic vessel function.
@ast
Vascular endothelial growth fa ...... of lymphatic vessel function.
@en
type
label
Vascular endothelial growth fa ...... of lymphatic vessel function.
@ast
Vascular endothelial growth fa ...... of lymphatic vessel function.
@en
prefLabel
Vascular endothelial growth fa ...... of lymphatic vessel function.
@ast
Vascular endothelial growth fa ...... of lymphatic vessel function.
@en
P2860
P1476
Vascular endothelial growth fa ...... of lymphatic vessel function.
@en
P2093
Kentaro Kajiya
Satoshi Hirakawa
P2860
P304
P356
10.2353/AJPATH.2006.060197
P407
P577
2006-10-01T00:00:00Z